Home Applications 017766 Application 017766
Type NDA
Sponsor B BRAUN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NEPHRAMINE 5.4% AMINO ACIDS INJECTABLE;INJECTION 5.4% (5.4GM/100ML) No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N017766-001 NEPHRAMINE 5.4% AMINO ACIDS 5.4% (5.4GM/100ML) INJECTABLE / INJECTION Approved before 1982
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N017766-001 NEPHRAMINE 5.4% 5.4% (5.4GM/100ML) INJECTABLE / INJECTION Approved before 1982 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N017766-001 NEPHRAMINE 5.4% 5.4% (5.4GM/100ML) INJECTABLE / INJECTION Approved before 1982 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N017766-001 NEPHRAMINE 5.4% 5.4% (5.4GM/100ML) INJECTABLE / INJECTION Approved before 1982 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N017766-001 NEPHRAMINE 5.4% 5.4% (5.4GM/100ML) INJECTABLE / INJECTION Approved before 1982 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 2 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0264-1909 NephrAmine HISTIDINE, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current 0264-1909 NephrAmine HISTIDINE, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 33341 SUPPL 2006-05-05 13897 SUPPL 2006-05-05 13896 SUPPL 2004-05-07 11059 SUPPL 2004-05-07 13895 SUPPL 2002-06-12